| - GRCh37:
- Chr11:61553259
- GRCh38:
- Chr11:61785787
| MYRF | | Cardiac-urogenital syndrome, Encephalitis/encephalopathy, mild, with reversible myelin vacuolization | Uncertain significance (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61544302
- GRCh38:
- Chr11:61776830
| MYRF | Q506*, Q515* | Cardiac-urogenital syndrome, Encephalitis/encephalopathy, mild, with reversible myelin vacuolization | Pathogenic (May 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61544274
- GRCh38:
- Chr11:61776802
| MYRF | | Cardiac-urogenital syndrome | Uncertain significance (Dec 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61548194
- GRCh38:
- Chr11:61780722
| MYRF | V806M | Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, Cardiac-urogenital syndrome | Uncertain significance (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61536759
- GRCh38:
- Chr11:61769287
| MYRF | G134fs, G143fs | Cardiac-urogenital syndrome | Pathogenic (Jul 1, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr11:61537905
- GRCh38:
- Chr11:61770433
| MYRF | Y207*, Y216* | Cardiac-urogenital syndrome | Pathogenic (Dec 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61533680
- GRCh38:
- Chr11:61766208
| MYRF | P120S, P129S | Cardiac-urogenital syndrome, Encephalitis/encephalopathy, mild, with reversible myelin vacuolization | Uncertain significance (Aug 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61548804
- GRCh38:
- Chr11:61781332
| MYRF | | Cardiac-urogenital syndrome, Encephalitis/encephalopathy, mild, with reversible myelin vacuolization | Uncertain significance (Jun 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61539013
- GRCh38:
- Chr11:61771541
| MYRF | S255fs, S264fs | Cardiac-urogenital syndrome, not provided | Pathogenic (May 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61539196
- GRCh38:
- Chr11:61771724
| MYRF | W313*, W322* | Cardiac-urogenital syndrome | Likely pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61544846
- GRCh38:
- Chr11:61777374
| MYRF | D559fs, D568fs | Cardiac-urogenital syndrome | Likely pathogenic (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61537896
- GRCh38:
- Chr11:61770424
| MYRF | H206fs, H215fs | Cardiac-urogenital syndrome | Likely pathogenic (Jan 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61551765
- GRCh38:
- Chr11:61784293
| MYRF | V1030fs, V1070fs | Cardiac-urogenital syndrome | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr11:61548711
- GRCh38:
- Chr11:61781239
| MYRF | T857A, T892A | Seizure, Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, Cardiac-urogenital syndrome
| Uncertain significance (Aug 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61546763
- GRCh38:
- Chr11:61779291
| MYRF | A672D, A681D | Cardiac-urogenital syndrome | Likely pathogenic (May 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61546795
- GRCh38:
- Chr11:61779323
| MYRF | L683V, L692V | Cardiac-urogenital syndrome | Likely pathogenic (Apr 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61548518
- GRCh38:
- Chr11:61781046
| MYRF | | Cardiac-urogenital syndrome | Pathogenic (Feb 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61539012-61539013
- GRCh38:
- Chr11:61771540-61771541
| MYRF | S255fs, S264fs | not provided, Non-immune hydrops fetalis, Cardiac-urogenital syndrome
| Pathogenic/Likely pathogenic (Dec 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61553338
- GRCh38:
- Chr11:61785866
| MYRF | A1083T, A1123T | Cardiac-urogenital syndrome | Uncertain significance (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61533645-61533661
- GRCh38:
- Chr11:61766173-61766189
| MYRF | G108fs, G117fs | Cardiac-urogenital syndrome | Pathogenic (Apr 6, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr11:61551793-61551794
- GRCh38:
- Chr11:61784321-61784322
| MYRF | E1041fs, E1081fs | Cardiac-urogenital syndrome | Pathogenic (Apr 6, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr11:61551071
- GRCh38:
- Chr11:61783599
| MYRF | R1040G, R1000G | Cardiac-urogenital syndrome | Pathogenic (Apr 6, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr11:61546805
- GRCh38:
- Chr11:61779333
| MYRF | R695H, R686H | Cardiac-urogenital syndrome | Uncertain significance (Nov 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61541626
- GRCh38:
- Chr11:61774154
| MYRF | G435R, G426R | Cardiac-urogenital syndrome, Abnormality of the genitourinary system, Congenital diaphragmatic hernia, Heart, malformation of | Pathogenic/Likely pathogenic (Mar 5, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr11:61541575-61541576
- GRCh38:
- Chr11:61774103-61774104
| MYRF | T419fs, T410fs | Cardiac-urogenital syndrome | Pathogenic (Jan 11, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr11:61548463
- GRCh38:
- Chr11:61780991
| MYRF | R840*, R805* | Cardiac-urogenital syndrome | Pathogenic (Jan 11, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr11:61547403
- GRCh38:
- Chr11:61779931
| MYRF | | not specified | Uncertain significance (Nov 21, 2016) | criteria provided, single submitter |